Engineers Gate Manager LP Seres Therapeutics, Inc. Transaction History
Engineers Gate Manager LP
- $5.55 Billion
- Q1 2025
A detailed history of Engineers Gate Manager LP transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 47,637 shares of MCRB stock, worth $670,728. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,637
Previous 84,986
43.95%
Holding current value
$670,728
Previous $70,000
52.86%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding MCRB
# of Institutions
61Shares Held
39.5MCall Options Held
103KPut Options Held
53K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$325 Million6.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$85.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.76MShares$24.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.62MShares$22.8 Million0.0% of portfolio
-
Ubs Group Ag1.46MShares$20.5 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $1.75B
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...